2389988-19-4
2389988-19-4
Chemical Structure
8-Benzyloxy-9-(β-D-xylofuranosyl)guanine
- CAS No.: 2389988-19-4
- Formula:C17H19N5O6
- Molecular Weight:389.36
IUPAC Name: 2-amino-8-(benzyloxy)-9-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one
InChIKey: RNSGUQLXDMZREX-JDTTZNEISA-N
SMILES: OC[C@@H]1[C@H](O)[C@@H](O)[C@H](N(C(OCC2=CC=CC=C2)=N3)C4=C3C(NC(N)=N4)=O)O1
Biological Activity: 8-Benzyloxy-9-(β-D-xylofuranosyl)guanine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
8-Benzyloxy-9-(β-D-xylofuranosyl)guanine | 8-Benzyloxy-9-(β-D-xylofuranosyl)guanine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
